Details checkedClinical trial listing onlyHistorical/discontinuedCheckedregistry

Intratympanic Lidocaine plus Dexamethasone Tinnitus Study

Also known as: Intra-tympanic injection of drugs, Lidocaine in tinnitus, Evaluation of Adding Lidocaine to Dexamethasone in Intra-tympanic Injection for Management of Tinnitus, NCT03265197

Investigator-led study

Primary source

Sponsor / Institution

Investigator-led study

Program Type

Therapeutic

Modality

Steroid/Anti-inflammatory

Stage

Phase 1

Status

Completed

Target Gene

—

Route / Mode

Intratympanic injection

Confidence

83%

Status Confidence

Status needs checking

Evidence Strength

Needs more support

Last Reviewed

2026-06-10

Geography

Unknown

Population

adult, tinnitus

Trial IDs

Mechanism

Completed investigator-led Phase 1 study comparing intratympanic lidocaine plus dexamethasone with dexamethasone-only intratympanic injection for tinnitus management.

Indications

Tinnitus

Notes

Verified and renamed from a generic intervention row. The registry describes one study of intratympanic lidocaine plus dexamethasone versus dexamethasone alone; the data-management arm is not a product or treatment.

Evidence & Sources

1 structured sources

clinicaltrials

Supports: canonicalName, aliases, company, allCompanies, isIndustrySponsored, programType, modality, mechanism...

IDs: NCT03265197

Open

Key Events

2015-03-01

Registry lists study start for intratympanic lidocaine plus dexamethasone tinnitus study

2016-04-01

Registry lists actual completion of intratympanic tinnitus study

Clinical Trials (1)